BEIJING, March 9, 2010 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products, today announced that it plans to release its fourth quarter and full year 2009 financial results after the market closes on Tuesday, March 16, 2010.
The Company will hold a conference call at 8:00 am ET on Wednesday, March 17, 2010 to discuss fourth quarter and full year 2009 results. Listeners may access the call by dialing the following numbers:
United States toll free: 1-877-832-1687
Northern China toll free: 10-800-713-0924
Southern China toll free: 10-800-130-0748
Germany toll free: 0-800-181-5287
International: 1-706-902-4004
Access Code: 59179823
A webcast will also be available through the Company's website at www.nkbp.com. A replay of the call will be accessible through March 24, 2010 by dialing the following numbers:
United States toll free: 1-800-642-1687
International: 1-706-645-9291
Access Code: 59179823
About China Nuokang Bio-Pharmaceutical Inc.
China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading biopharmaceutical company in China focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. The Company provides a diversified portfolio of products across more than 2,400 hospitals in China. Nuokang's principal products include Baquting®, China's leading hemocoagulase product by market share, and Aiduo®, a cardiovascular stress imaging agent. The Company's product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. Please visit www.nkbp.com or www.lnnk.com for more information.